Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...

For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited ...